Brinker Capital’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
F
EHC
Brinker Capital's NVO Position: Q2 2020 in Review
Brinker Capital increased its Novo Nordisk (NVO) stake by 17% in Q2 2020, buying an estimated $640K and bringing the position to 134,878 shares worth $4.42M. The position accounts for 0.14% of the portfolio, ranked #160.
Brinker Capital first reported a position in NVO in Q1 2016 and has held it in 17 quarters since. The position peaked at $11.6M in Q4 2017. 661 funds tracked by Wall St. Rank hold NVO as of Q2 2020.
- Brinker Capital held 134,878 shares of Novo Nordisk worth $4.42M as of Q2 2020.
- Brinker Capital bought 20,056 Novo Nordisk shares in Q2 2020, an estimated $640K.
- Novo Nordisk made up 0.14% of Brinker Capital's portfolio in Q2 2020, its #160 holding.
- Brinker Capital first reported a position in Novo Nordisk in Q1 2016 and has held it in 17 quarters since.
- Brinker Capital's Novo Nordisk position peaked at $11.6M in Q4 2017.
- 661 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2020.
Based on Brinker Capital's 13F filing for Q2 2020, filed 30 Jul 2020.